Literature DB >> 2229359

Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei.

L R Ashdown1, J M Koehler.   

Abstract

One hundred clinical isolates of Pseudomonas pseudomallei from humans were tested for their ability to produce extracellular, biologically active substances which are thought to contribute to the virulence of Pseudomonas species. All isolates produced at least on extracellular enzyme; 91 strains were positive for lecithinase, lipase, and protease; but none was positive for elastase. Ninety-three strains produced a hemolysin which was detectable around the heavy growth on saline-washed sheep erythrocyte brain heart infusion agar but not demonstrable around individual colonies or in broth culture filtrate. In contrast, a hemolysin which was cytolytic around individual colonies of P. pseudomallei on the assay plate and in broth culture filtrate was exhibited by four strains. By using one of these four isolates as the test strain, the latter hemolysin was characterized further. It was heat labile, most active in an acid environment (pH 5.5), and cytolytic in broth culture filtrate for a variety of animal and human erythrocytes. Sterols, particularly cholesterol and 7-dehydrocholesterol, inhibited its hemolytic activity, but the activity was not enhanced by reducing agents or suppressed by reagents which modify sulfhydryl-activated hemolysins. A nonhemolytic mutant of the test strain of P. pseudomallei retained the extracellular enzymes of its parent, indicating that the hemolysin was not a lecithinase, lipase, or protease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229359      PMCID: PMC268171          DOI: 10.1128/jcm.28.10.2331-2334.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa.

Authors:  P A Sokol; D E Ohman; B H Iglewski
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

2.  Lecithinase production by gramnegative bacteria.

Authors:  M T ESSELMANN; P V LIU
Journal:  J Bacteriol       Date:  1961-06       Impact factor: 3.490

3.  Endotoxic properties of Pseudomonas pseudomallei.

Authors:  F T RAPAPORT; J W MILLAR; J RUCH
Journal:  Arch Pathol       Date:  1961-04

4.  Toxins of Pseudomonas pseudomallei. II. Characterization.

Authors:  R J HECKLY; C NIGG
Journal:  J Bacteriol       Date:  1958-10       Impact factor: 3.490

5.  Survey of hemolysin production among species of pseudomonads.

Authors:  P V LIU
Journal:  J Bacteriol       Date:  1957-12       Impact factor: 3.490

6.  Comparative studies of the genus Malleomyces and selected Pseudomonas species. I. Morphological and cultural characteristics.

Authors:  P W WETMORE; W S GOCHENOUR
Journal:  J Bacteriol       Date:  1956-07       Impact factor: 3.490

Review 7.  The pseudomallei group: a review.

Authors:  C Howe; A Sampath; M Spotnitz
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

8.  Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis.

Authors:  A I McKevitt; D E Woods
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

9.  The prevalence of human melioidosis in Northern Queensland.

Authors:  L R Ashdown; R W Guard
Journal:  Am J Trop Med Hyg       Date:  1984-05       Impact factor: 2.345

10.  DIFFERENTIATION OF EXOTOXIN AND OTHER BIOLOGICALLY ACTIVE SUBSTANCES IN PSEUDOMONAS PSEUDOMALLEI FILTRATES.

Authors:  R J HECKLY
Journal:  J Bacteriol       Date:  1964-12       Impact factor: 3.490

View more
  19 in total

1.  Cloning and characterization of a nonhemolytic phospholipase C gene from Burkholderia pseudomallei.

Authors:  S Korbsrisate; N Suwanasai; A Leelaporn; T Ezaki; Y Kawamura; S Sarasombath
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  Presence of type III secretion genes in Burkholderia pseudomallei correlates with Ara(-) phenotypes.

Authors:  C Winstanley; C A Hart
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Hemolytic activity in the periodontopathogen Porphyromonas gingivalis: kinetics of enzyme release and localization.

Authors:  L Chu; T E Bramanti; J L Ebersole; S C Holt
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

4.  Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei.

Authors:  S Häussler; M Nimtz; T Domke; V Wray; I Steinmetz
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

5.  Evidence of Burkholderia pseudomallei-specific immunity in patient sera persistently nonreactive by the indirect hemagglutination assay.

Authors:  Patrick N A Harris; Natasha L Williams; Jodie L Morris; Natkunam Ketheesan; Robert E Norton
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

6.  Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei.

Authors:  L E Bryan; S Wong; D E Woods; D A Dance; W Chaowagul
Journal:  Can J Infect Dis       Date:  1994-07

Review 7.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  Intracellular survival of Burkholderia pseudomallei.

Authors:  A L Jones; T J Beveridge; D E Woods
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Burkholderia pseudomallei Requires Zn(sup2+) for Optimal Exoprotease Production in Chemically Defined Media.

Authors:  G Percheron; F Thibault; J Paucod; D Vidal
Journal:  Appl Environ Microbiol       Date:  1995-08       Impact factor: 4.792

10.  Partial characterization of Streptococcus suis type 2 hemolysin.

Authors:  I Feder; M M Chengappa; B Fenwick; M Rider; J Staats
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.